Search Within

Tiffany A Traina

Formats
  1. Meeting Abstract (137)
  2. Journal Article (95)
  3. Book Section (8)
  4. Review (6)
  5. Book Whole (2)
  6. Guidelines (1)
  7. Miscellaneous (1)
Groups
  1. Breast Medicine Service (250)
  2. Department of Medicine (250)
  3. Solid Tumor Oncology Division (250)
  4. Survivorship Research (250)
  5. Epidemiology and Biostatistics (99)
  6. Biostatistics Service (85)

More Groups

People
  1. Clifford Hudis (95)
  2. Sujata Patil (62)
  3. Ayca Gucalp (59)
  4. Larry Norton (56)
  5. Maura Dickler (34)
  6. Diana Lake (33)

More People

Years
  1. 2025 (3)
  2. 2024 (16)
  3. 2023 (8)
  4. 2022 (13)
  5. 2021 (17)
  6. 2020 (16)

More Years

Publications
  1. Journal of Clinical Oncology (76)
  2. Cancer Research (44)
  3. Breast Cancer Research and Treatment (16)
  4. Annals of Oncology (14)
  5. Clinical Cancer Research (11)
  6. Clinical Breast Cancer (7)

More Publications

Publishers
  1. American Society of Clinical Oncology (77)
  2. American Association for Cancer Research (55)
  3. Springer (33)
  4. Elsevier Inc. (23)
  5. Oxford University Press (16)
  6. Future Medicine (5)

More Publishers

Results (250)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 2 feasibility study of dose-dense doxorubicin and cyclophosphamide (AC) followed by eribulin mesylate with or without prophylactic growth factor (GF) for adjuvant treatment of early-stage breast cancer (EBC)
    Meeting Abstract

    Traina, T. A.; Kaufman, P. A.; Cadoo, K. A.; Hudis, C. A.; Chang, C.; Berrak, E.; Song, J.; Cox, D.; Seidman, A. D.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A phase 2 single-arm study of the clinical activity and safety of enzalutamide in patients with advanced androgen receptor-positive triple-negative breast cancer
    Meeting Abstract

    Traina, T. A.; O'Shaughnessy, J.; Kelly, C. M.; Schwartzberg, L. S.; Gucalp, A.; Peterson, A. C.; Tudor, I. C.; Blaney, M. E.; Steinberg, J. L.; Trudeau, M. E.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Enzalutamide plus exemestane: A pilot study to assess safety, pharmacokinetics, and effects on circulating estrogens in women with advanced hormone-positive breast cancer
    Meeting Abstract

    Schwartzberg, L. S.; Yardley, D. A.; Elias, A. D.; Patel, M. R.; Gucalp, A.; Burris, H. A.; Peterson, A. C.; Hannah, A. L.; Blaney, M. E.; Gibbons, J.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Adjuvant palbociclib (P) plus endocrine therapy (ET) for hormone receptor positive (HR plus ) breast cancer: A phase II feasibility study
    Meeting Abstract

    Mayer, E. L.; Gropper, A. B.; Tung, N. M.; Higgins, M. J.; Traina, T. A.; Barry, W. T.; Winer, E. P.; Burstein, H. J.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • TBCRC030: A randomized, phase II study of preoperative cisplatin versus paclitaxel in patients (pts) with BRCA1/2-proficient triple-negative breast cancer (TNBC)-Evaluating the homologous recombination deficiency (HRD) biomarker
    Meeting Abstract

    Mayer, E. L.; Vaz-Luis, I.; Richardson, A. L.; Perou, C. M.; Tung, N. M.; Abramson, V. G.; Anders, C. K.; Forero-Torres, A.; Marcom, P. K.; Miller, K.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase II feasibility study of paclitaxel (T) with trastuzumab (H) and lapatinib (L) for node-negative, HER2-positive breast cancer (BC)
    Meeting Abstract

    Iyengar, N. M.; Fornier, M. N.; Sugarman, S.; Theodoulou, M.; Troso-Sandoval, T. A.; D'Andrea, G.; Drullinsky, P.; Fasano, J.; Gajria, D.; Goldfarb, S. B.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Identification of biomarkers to predict response to single-agent platinum chemotherapy in metastatic triple-negative breast cancer (mTNBC): Correlative studies from TBCRC009
    Meeting Abstract

    Isakoff, S. J.; He, L.; Mayer, E. L.; Goss, P. E.; Traina, T. A.; Carey, L. A.; Krag, K.; Liu, M. C.; Rugo, H. S.; Stearns, V.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • CK14, FOXA1, and androgen receptor (AR) expression in patients (pts) with triple-negative breast cancer (TNBC)
    Meeting Abstract

    Gucalp, A.; Krasne, M. D.; Jakate, K. A.; Drill, E. N.; Wen, Y. H.; Akram, M.; Ho, A. Y.; Gupta, G. P.; Brogi, E.; Hudis, C. A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A virtual consult service to optimize clinical trial participation in patients with metastatic breast cancer
    Meeting Abstract

    Cadoo, K. A.; Shah, P. D.; Charen, A. S.; Bromberg, J.; Comen, E. A.; D'Andrea, G.; Dang, C. T.; Gilewski, T.; Gucalp, A.; Lake, D.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Palbociclib: An evidence-based review of its potential in the treatment of breast cancer
    Journal Article

    Cadoo, K. A.; Gucalp, A.; Traina, T. A.
    Breast Cancer: Targets and Therapy (2014)

    Fulltext@MSK | Save